About: CAPRISA 004     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:Test100791078, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon
http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FCAPRISA_004&invfp=IFP_OFF&sas=SAME_AS_OFF

CAPRISA 004 is the name of a clinical trial conducted by CAPRISA. This particular study was the first to show that a topical gel could reduce a person's risk of contracting HIV. The gel used in the study contained a microbicide.

AttributesValues
rdf:type
rdfs:label
  • Caprisa 004 (ca)
  • CAPRISA 004 (en)
rdfs:comment
  • CAPRISA 004 és el nom de l'assig clínic dut a terme pel Centre for the AIDS Programme of Research in South Africa conegut com a CAPRISA. El títol oficial de l'estudi era «Phase IIb Trial to Assess the Safety and Effectiveness of the Vaginal Microbicide 1% Tenofovir Gel for the Prevention of HIV Infection in Women in South Africa». En concret, aquest estudi intentava demostrar l'eficàcia d'un gel com a mecanisme per a reduir la probabilitat d'infectar-se pel VIH durant una relació coital. El component clau d'aquest gel era una microbicida. (ca)
  • CAPRISA 004 is the name of a clinical trial conducted by CAPRISA. This particular study was the first to show that a topical gel could reduce a person's risk of contracting HIV. The gel used in the study contained a microbicide. (en)
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
has abstract
  • CAPRISA 004 és el nom de l'assig clínic dut a terme pel Centre for the AIDS Programme of Research in South Africa conegut com a CAPRISA. El títol oficial de l'estudi era «Phase IIb Trial to Assess the Safety and Effectiveness of the Vaginal Microbicide 1% Tenofovir Gel for the Prevention of HIV Infection in Women in South Africa». En concret, aquest estudi intentava demostrar l'eficàcia d'un gel com a mecanisme per a reduir la probabilitat d'infectar-se pel VIH durant una relació coital. El component clau d'aquest gel era una microbicida. (ca)
  • CAPRISA 004 is the name of a clinical trial conducted by CAPRISA. This particular study was the first to show that a topical gel could reduce a person's risk of contracting HIV. The gel used in the study contained a microbicide. (en)
gold:hypernym
prov:wasDerivedFrom
page length (characters) of wiki page
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is award of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 47 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software